P-gp upregulation may be blocked by natural curcuminoids, a novel class of chemoresistance-preventing agent
Authors:
- 27 September 2012
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 7 (1) , 115-121
Abstract
Once multidrug resistance (MDR) occurs in cancer cells, it is very difficult to reverse since overexpression of P-glycoprotein (P-gp) is accompanied by altered expression of numerous other activated target genes. Previously, we reported that curcumin pretreatment would be an ideal method to prevent acquired drug resistance induced by adriamycin, administered prior to the development of MDR. To further confirm the previous results, we examined the potency of 3 forms of curcuminoids present in turmeric as potent preventers of acquired drug resistance. K562 cells were pretreated with or without curcuminoids for 24 h and co-incubated with adriamycin. P-gp and mdr1 mRNA levels were analyzed separately by flow cytometry and quantitative real-time RT-PCR. In addition, we performed an MTT assay to determine the adriamycin-induced cytotoxicity with or without pretreatment with curcuminoids. Short- and long-term exposure of native K562 cells to adriamycin led to upregulation of P-gp and formation of acquired drug resistance. However, after pretreatment with curcuminoids, the above processes were significantly inhibited. The MTT assay examined the enhanced effect of curcuminoids on adriamycin‑induced cytotoxicity. Results from western blotting showed that curcuminoids could inhibit the adriamycin-induced increase of NF-κB nuclear translocation and activation. Finally, under the long-term exposure model, we proved that curcumin was capable of blocking the occurrence of MDR in the cell line throughout the 56-day culture period. This study reveals that curcuminoids have the potency to block the upregulation of P-gp and its mRNA induced by short- and long-term exposure to adriamycin. Curcuminoids may be a novel class of potent chemoresistance-preventing agent with high safety and the potential for widespread clinical use.Keywords
This publication has 24 references indexed in Scilit:
- Curcumin prevents induced drug resistance: A novel function?Chinese Journal of Cancer Research, 2011
- Tetrandrine prevents acquired drug resistance of K562 cells through inhibition of mdr1 gene transcriptionJournal of Cancer Research and Clinical Oncology, 2009
- Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPAThe Journal of Nutritional Biochemistry, 2009
- Curcumin Inhibits Tumor Growth and Angiogenesis in Ovarian Carcinoma by Targeting the Nuclear Factor-κB PathwayClinical Cancer Research, 2007
- Schisandrin B: A dual inhibitor of P-glycoprotein and multidrug resistance-associated protein 1Cancer Letters, 2007
- The molecular basis of multidrug resistance in cancer: The early years of P‐glycoprotein researchFEBS Letters, 2005
- Role of nuclear factor-κ B in melanomaCancer and Metastasis Reviews, 2005
- P-glycoprotein (MDR1) Expression in Leukemic Cells Is Regulated at Two Distinct Steps, mRNA Stabilization and Translational InitiationJournal of Biological Chemistry, 2003
- Multidrug resistance in cancer: role of ATP–dependent transportersNature Reviews Cancer, 2002
- Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell LineScience, 1992